J. Maltzman
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 18
- HER2/EGFR in Cancer Research 12
- Cancer Treatment and Pharmacology 10
- Bone health and treatments 1
-
- Advanced Breast Cancer Therapies 14
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Lisa O’Rourke (17 shared papers)Stephen Johnston (9 shared papers)Allison Florance (9 shared papers)Mark D. Pegram (6 shared papers)Xavier Pivot (7 shared papers)John Pippen (6 shared papers)Henry Gómez (5 shared papers)Michael F. Press (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (5 papers)The Oncologist (3 papers)The Breast (2 papers)Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomPeru
In The Last Decade
J. Maltzman
21 papers receiving 1.2k citations
J. Maltzman's Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 912
- Cancer Research 245
- Pulmonary and Respiratory Medicine 399
- Radiology, Nuclear Medicine and Imaging 237
- Genetics 91
Countries citing papers authored by J. Maltzman
This map shows the geographic impact of J. Maltzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Maltzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Maltzman more than expected).
Fields of papers citing papers by J. Maltzman
This network shows the impact of papers produced by J. Maltzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Maltzman. The network helps show where J. Maltzman may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Maltzman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer Hit paper breakdown → | 2009 | 806 |
| 2 | 2010 | 161 | |
| 3 | 2009 | 139 | |
| 4 | 2009 | 53 | |
| 5 | 2009 | 27 | |
| 6 | 2010 | 24 | |
| 7 | 2011 | 19 | |
| 8 | 2010 | 13 | |
| 9 | 2011 | 7 | |
| 10 | 2009 | 6 | |
| 11 | 2009 | 5 | |
| 12 | 2007 | 5 | |
| 13 | 2009 | 4 | |
| 14 | 2009 | 4 | |
| 15 | 2009 | 4 | |
| 16 | 2009 | 3 | |
| 17 | 2009 | 2 | |
| 18 | 2009 | 2 | |
| 19 | 2009 | 2 | |
| 20 | 2009 | 1 |
About J. Maltzman
J. Maltzman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (14 papers), HER2/EGFR in Cancer Research (12 papers), Cancer Treatment and Pharmacology (10 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Treatments and Mutations (3 papers), Bone health and treatments (1 paper), Breast Cancer Treatment Studies (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Oncology (912 citations), Cancer Research (245 citations), Pulmonary and Respiratory Medicine (399 citations), Radiology, Nuclear Medicine and Imaging (237 citations) and Genetics (91 citations). J. Maltzman has collaborated with scholars based in United States, United Kingdom and Peru. Frequent co-authors include Lisa O’Rourke, Stephen Johnston, Allison Florance, Mark D. Pegram, Xavier Pivot, John Pippen, Henry Gómez, Michael F. Press, Alexey Manikhas and Mikhail Lichinitser. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Oncologist, The Breast and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.